Why Electromed, Inc.’s (ELMD) Stock Is Down 13.98%
As of Wednesday, August 26, Electromed, Inc.’s ELMD share price has dipped by 13.98%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company provides SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
Commentary & Analysis
Why Electromed, Inc.’s (ELMD) Stock Is Down 19.09%
As of Wednesday, August 26, Electromed, Inc.’s ELMD share price has dipped by 19.09%, which has investors questioning if this is right time to buy.Omar Beirat
Is Electromed, Inc. (ELMD) Overvalued?
We dive into why Electromed, Inc. (ELMD) could be considered overvalued on 2026-08-17, based on AAII’s Value Score and Grade.Tudor Pop
Why Electromed, Inc.’s (ELMD) Stock Is Up 5.02%
As of Thursday, July 09, Electromed, Inc.’s ELMD share price has surged by 5.02%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Electromed, Inc.’s (ELMD) Stock Is Up 5.37%
As of Friday, June 26, Electromed, Inc.’s ELMD share price has surged by 5.37%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Financial Summary
| Share Statistics | ELMD | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $229.4 | $425.5 | 29% |
|
| Shares Out (Mil) | 8.7 | 40.4 | 20% |
|
| Institutional Ownership | 77.9% | 83.0% | 47% |
|
| Float (Mil) | 6.9 | 34.7 | 15% |
|
| Beta | 0.51 | 0.85 | 29% |
|
| Avg Daily Volume (000s) | 38 | 287 | 27% |
|
| Price Change (52-week) |
13.3% | 65.2% | 63% |
|
| Growth | ELMD | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 15.6% | 11.8% | 74% |
|
| Net Income (5yr) | 36.3% | (5.5%) | 89% |
|
| EPS (5yr) | 36.9% | 10.7% | 87 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 31.1% | (15.6%) | 86% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | ELMD | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $74 | $128 | 24% |
|
| Net Income (TTM) (Mil) | $11 | ($9) | 46% |
|
| EPS (TTM) | $1.367 | ($0.400) | 65% |
|
| Operating Cash Flow (TTM) (Mil) | $10 | ($2) | 38% |
|
| Net Cash Flow (TTM) (Mil) | $5 | $1 | 52% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $23 | 10% |
|
| Enterprise Value (Q1) (Mil) | $246 | $399 | 28% |
|
| Valuation | ELMD | Industry Median |
Percentile (All Stocks) |
|
| P/B | 4.29 | 2.49 | 76% |
|
| P/E | 21.3 | 28.5 | 55% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 0.6 | 1.5 | 29% |
|
| Ratios | ELMD | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 78.5% | 59.3% | 88% |
|
| Net Margin | 15.3% | (6.9%) | 72% |
|
| ROA | 18.8% | (11.8%) | 95% |
|
| ROE | 23.3% | (10.1%) | 83% |
|
| Liabilities to Assets | 18.5% | 47.2% | 12% |
|
| F-Score | 8 | 4 | 93% |
|
Passing Stock Screens
As of 10/29/2026, from a list of 60 stock screening strategies,
GURU STRATEGY
Buffettology: EPS Growth
Factors: Quality, Growth
Buffett approach seeking consumer monopolies selling at a reasonable price.
| Performance Since Inception: | 12.2% |
| +/- S&P 500: | +4.7 |
FACTOR STRATEGY
Return on Equity Screen
Factors: Quality, Growth
A screen that identifies stocks with above average earnings and sales growth that have consistently outperformed their peers measured by ROE.
| Performance Since Inception: | 12.7% |
| +/- S&P 500: | +5.2 |
GURU STRATEGY
Templeton Screen
Factors: Value, Growth
Favorable margins, consistent earnings growth and price-earnings ratios below historical norms.
| Performance Since Inception: | 9.4% |
| +/- S&P 500: | +1.9 |
GURU STRATEGY
Wanger Screen
Factors: Value, Size, Growth
First introduced in May 1997, this approach focuses on limiting the risks of investing in small-cap stocks.
| Performance Since Inception: | 12.2% |
| +/- S&P 500: | +4.7 |
